Friday, December 9, 2016

UPDATE 1-Synergy Pharma's irritable bowel drug succeeds in key study

Dec 9 (Reuters) - Synergy Pharmaceuticals Inc said

its experimental once-daily tablet, plecanatide, met the main

goal of a late-stage study on irritable bowel syndrome patients

with constipation...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)